Latest Harness Therapeutics News & Updates

See the latest news and media coverage for Harness Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Harness Therapeutics

Biotechnology company developing neurodegeneration therapies

harnesstx.com
Headquarters
Cambridge, United Kingdom
Founded year
2023
Company type
Private company
Number of employees
30–50

Latest news about Harness Therapeutics

Company announcements

  • Harness Therapeutics

    Harness Therapeutics nominates HRN001 for Huntington’s disease

    HRN001 is a first-in-class antisense oligonucleotide upregulating FAN1. The company forms a Clinical Advisory Board to guide clinical progression in 2027.

  • Harness Therapeutics

    Harness Therapeutics appoints Meenu Chhabra Karson as Board Chair

    She brings over 20 years of biopharma experience, including fundraising, partnerships, and leadership roles at Samsara Therapeutics and others. Her expertise supports growth in neurodegenerative therapeutics.

  • Harness Therapeutics

    Harness Therapeutics announces MISBA Duo platform launch

    The platform enables simultaneous upregulation and downregulation of two targets. It collaborates with Ono Venture Investment on an R&D program for a rare triplet repeat disorder.

  • Harness Therapeutics

    Harness Therapeutics appoints experts to its Scientific Advisory Board

    The SAB includes leaders in genetics, biology, and Huntington’s disease to guide HRN001 development and pipeline expansion. CTA-enabling studies for HRN001 start in 2025.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Harness Therapeutics

Track Harness Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Harness Therapeutics competitors & trending companies

Browse news for competitors to Harness Therapeutics and other trending companies.